Literature DB >> 8436132

Involvement of the Arg179 in the active site of human IL-6.

V Fontaine1, R Savino, R Arcone, L de Wit, J P Brakenhoff, J Content, G Ciliberto.   

Abstract

Three internal-amino acid deletions of amino acids 171-179 of human interleukin 6 (IL-6) were introduced at the cDNA level. While all deletion proteins were biologically inactive, immunoprecipitations with a set of conformation-specific anti-(IL-6) monoclonal antibodies showed that only mutant delta 177-179 does not present major alterations in folding. This finding, together with the observation that delta 177-179 is not able to compete with IL-6 for binding to the soluble human IL-6 receptor, suggested that some or all of these three residues participate to the composition of the receptor-binding site of human IL-6. A large number of single-amino-acid-substitution mutants were generated in residues 177, 178 and 179. Their detailed analysis revealed that Arg179 is crucial for activity in mouse cells, because all amino acid substitutions in this position cause a dramatic drop of biological activity on murine hybridoma cells without affecting the overall protein folding. The only substitution which preserved some residual activity was the conservative Arg to Lys change. This demonstrates the absolute requirement for a positive charge in position 179 for the interaction of human IL-6 with its receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436132     DOI: 10.1111/j.1432-1033.1993.tb17605.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.

Authors:  H Li; H Wang; J Nicholas
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Curcumin and capsaicin modulates LPS induced expression of COX-2, IL-6 and TGF-β in human peripheral blood mononuclear cells.

Authors:  Thriveni Vasanthkumar; Manjunatha Hanumanthappa; Rangaswamy Lakshminarayana
Journal:  Cytotechnology       Date:  2019-09-05       Impact factor: 2.058

Review 3.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

4.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.

Authors:  W Somers; M Stahl; J S Seehra
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

6.  Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure.

Authors:  R Savino; A Lahm; M Giorgio; A Cabibbo; A Tramontano; G Ciliberto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Functional characterization of W147A: a high-affinity interleukin-11 antagonist.

Authors:  Nicholas Underhill-Day; Lisa A McGovern; Natalia Karpovich; Helen J Mardon; Victoria A Barton; John K Heath
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

8.  Molecular cloning and sequencing of interleukin 6 cDNA fragments from the harbor seal (Phoca vitulina), killer whale (Orcinus orca), and Southern sea otter (Enhydra lutris nereis).

Authors:  D P King; M D Schrenzel; M L McKnight; T H Reidarson; K D Hanni; J L Stott; D A Ferrick
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

9.  Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.

Authors:  A Hammacher; L D Ward; J Weinstock; H Treutlein; K Yasukawa; R J Simpson
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

10.  Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.

Authors:  R Savino; A Lahm; A L Salvati; L Ciapponi; E Sporeno; S Altamura; G Paonessa; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.